Treating COVID-19 with Seraph 100

The Seraph 100 binds with SARS-CoV-2, the virus that causes COVID-19. Clinicians have reported a reduction in inflammatory markers such as IL-6, d-dimer, and ferritin. Other anecdotal observations include improved hemodynamic stabilization, reduction of vasopressors and fractionally inspired oxygen, and avoidance or reduced time of mechanical ventilation.

The Seraph 100:

  • Is the first device with an indication to reduce pathogens in the bloodstream in adjunction to antibiotic therapy*
  • Reduces a broad spectrum of drug-susceptible and drug-resistant pathogens
  • Can be used as an early intervention prior to pathogen identification
  • Has a novel biomimetic binding surface that prevents bacteria from developing resistance from it

00:00: Introductions
00:50: Seraph 100 Overview to Treat COVID-19 by Dr. Mink Chawla
12:35: Clinical Practice & Use of the Seraph 100 by Dr. Sean Barnett 
35:50: Questions and Answers  


Clinical Practice and Hands-On Experience:
User Case Study Presentations

Seraph 100 User Group III –
September 28, 2020

Clinicians review latest cases from Eisenhower Medical Center

00:00: Case Discussion
02:43: Introduction
03:45: Product Overview
06:44: Case Study Presentation
25:40: Q&A


Seraph 100 User Group II – September 4, 2020

Clinicians review COVID-19 Cases from Forrest General

00:00: Introduction 01:45: Product Overview
16:38: Case Study Presentation
37:34: Q&A


Seraph 100 in the Field

Seraph 100 Microbind Affinity Blood Filter Technology

Seraph 100 is being used in hospitals across the United States, including several military hospitals. Several hospitals have presented their findings:

Providers Using Seraph 100
in the United States

Please read our information sheet to learn more about the device and how to order it.

For FDA guidance on the use of Seraph 100 on COVID-19 patients, please follow the links below:


NOVEMBER 23, 2021
Extracorporeal Pathogen Adsorption for the Treatment of Bloodstream Infections in the Critically Ill

SEPTEMBER 14, 2021
Sepsis Alliance: Hope for Critically Ill COVID-19 Patients

JUNE 9, 2021
Clinical Use and Lessons Learned with Seraph 100

MAY 17, 2021
COVID-19 Webinar: A Role for Seraph 100

NOVEMBER 11, 2020
More Than Pathogen Reduction – Seraph 100 in COVID-19

JUNE 24, 2020
COVID-19 Webinar: A Role for Seraph 100